The VacA toxin secreted by Helicobacter pylori is considered to be an important virulence factor in the pathogenesis of peptic ulcer disease and gastric cancer. VacA monomers self-assemble into water-soluble oligomeric structures and can form anion-selective membrane channels. The goal of this study was to characterize VacA-VacA interactions that may mediate assembly of VacA monomers into higher order structures. We investigated potential interactions between two domains of VacA (termed p-33 and p-55) by using a yeast two-hybrid system. p-33/p-55 interactions were detected in this system, whereas p-33/p-33 and p-55/p-55 interactions were not detected. Several p-33 proteins containing internal deletion mutations were unable to interact with wildtype p-55 in the yeast two-hybrid system. Introduction of these same deletion mutations into the H. pylori vacA gene resulted in secretion of mutant VacA proteins that failed to assemble into large oligomeric structures and that lacked vacuolating toxic activity for HeLa cells. Additional mapping studies in the yeast two-hybrid system indicated that only the N-terminal portion of the p-55 domain is required for p-33/p-55 interactions. To characterize further p-33/p-55 interactions, we engineered an H. pylori strain that produced a VacA toxin containing an enterokinase cleavage site located between the p-33 and p-55 domains. Enterokinase treatment resulted in complete proteolysis of VacA into p-33 and p-55 domains, which remained physically associated within oligomeric structures and retained vacuolating cytotoxin activity. These results provide evidence that interactions between p-33 and p-55 domains play an important role in VacA assembly into oligomeric structures.
Most virulent H. pylori strains secrete a cytotoxin known as VacA into the extracellular space (5) (6) (7) (8) . Several lines of evidence indicate that VacA contributes to the capacity of H. pylori to colonize the stomach and that this toxin is an important virulence factor in the pathogenesis of peptic ulceration and gastric cancer (6 -12) . The most extensively characterized activity of VacA is its capacity to induce vacuolation in mammalian cells (5, 13) . The membranes of these VacA-induced vacuoles contain markers for late endosomal and lysosomal compartments (14) . The precise mechanism of VacA-induced vacuole formation is not completely understood but is thought to involve binding of the toxin to the plasma membrane, internalization of the toxin, and action of the toxin in an intracellular site (6 -8) . One model proposes that VacA forms anionselective channels in the membrane of late endocytic compartments (6 -8, 15, 16) . In addition to inducing the formation of intracellular vacuoles, VacA causes multiple other effects on target cells, including depolarization of the membrane potential (16, 17) , permeabilization of epithelial monolayers (18) , apoptosis (19 -22) , detachment of epithelial cells from the basement membrane (12) , interference with the process of antigen presentation (23) , and inhibition of T lymphocyte activation (24) .
The vacA gene is translated as a 139 -140-kDa protoxin and shows no striking similarity to any other known bacterial toxin (5, 11, 25, 26) . Upon expression, this protoxin undergoes N-and C-terminal processing to yield a mature 88-kDa secreted VacA toxin (27) . The mature secreted 88-kDa VacA toxin can undergo spontaneous proteolytic degradation into fragments that are about 33 and 55 kDa in mass (11, (27) (28) (29) . This degradation has been observed especially when preparations of the purified toxin are stored for prolonged periods (11, 28) . The site of proteolytic cleavage is predicted to be located within a hydrophilic surface-exposed loop (11, 27) . It has been presumed that the two fragments (termed p-33 and p-55) represent two domains or subunits of VacA (11, 30, 31) . It should be noted that the nomenclature for describing these fragments has not been uniform; several previous studies have described 37 -and 58-kDa fragments (11, 30, (32) (33) (34) (35) (36) . In the current study, we designate the two fragments as p-33 and p-55, based on the results of mass spectrometry analysis (27) .
Previous studies have identified specific functions that are attributable to either the p-33 or the p-55 domain. Several lines of evidence indicate that amino acid sequences within the p-55 domain (located at the C terminus of the mature secreted toxin) mediate binding of VacA to host cells (28, 31, 37, 38) . VacA binding to cells is inhibited by antiserum reactive with the p-55 fragment but not inhibited by antiserum to the p-33 fragment (28) . Also, a truncated form of VacA containing mainly the p- 55 VacA fragment was reported to bind to target cells in a manner similar to the full-length VacA (31) . Amino acid sequences located within a hydrophobic region near the N terminus (within the p-33 domain) are required for membrane channel formation by VacA (39, 40) . When expressed in transiently transfected cells, neither the p-33 nor the p-55 domain alone is sufficient for vacuolating toxin activity (32, 34, 41) . In transiently transfected cells, expression of the entire p-33 domain as well as about 111 amino acids from the N terminus of the p-55 domain is required for vacuolating toxin activity (32) .
Secreted VacA proteins assemble into large water-soluble and flower-shaped structures composed predominantly of 12-14 VacA monomers (29, 30, 42) . Assembly of VacA into oligomeric structures is presumably required for membrane channel formation. This hypothesis is supported by electron microscopy studies in which VacA associated with membranes appears as oligomeric structures (15, 42) , as well as electrophysiologic studies in which the kinetics of membrane channel formation by VacA have been investigated (43) . Thus far, the process by which VacA assembles into higher order structures has not been studied in any detail. Therefore, the goal of this study was to characterize the interactions that may mediate assembly of VacA into oligomeric structures. We describe here several lines of evidence indicating that interactions occur between the p-33 and p-55 domains of VacA, and we identify candidate regions within these two domains that are required for these interactions. In addition, we propose that interactions between p-33 and p-55 domains are essential for the assembly of VacA into oligomeric structures and for VacA vacuolating cytotoxin activity.
EXPERIMENTAL PROCEDURES
Bacterial and Yeast Strains, Media, and Growth Condition-H. pylori strain 60190 (ATCC 49503) was grown on trypticase soy agar plates containing 5% sheep blood at 37°C in ambient air containing 5% CO 2 . Liquid cultures were grown in sulfite-free Brucella broth supplemented with either 5% fetal bovine serum or 0.5% activated charcoal. Escherichia coli XL1-Blue (Stratagene) was used for plasmid propagation and was grown on Luria-Bertani (LB) broth or LB agar at 37°C. Yeast two-hybrid experiments were performed with Saccharomyces cerevisiae strain YRG-2 (MAT␣ ura3-52 his3-200 ade2-101 lys2-801 trp1-901 leu2-3,112 gal4-542 gal80-538 LYS2::UAS GAL1 -TATA GAL1 -HIS3 URA3:: UASGAL4 17mers(x3) -TATA CYC1 -lacZ) (Stratagene). Yeast strains were grown in rich medium (yeast extract, peptone, dextrose (YPAD)) or in synthetic defined (SD) minimal medium (supplemented with required amino acids and glucose) at 30°C as described in the GAL4 Two-hybrid Phagemid manual (Stratagene).
Construction of VacA Yeast Two-hybrid Vectors Containing vacA Fragments-vacA sequences encoding the wild-type p-33 and p-55 VacA domains were PCR-amplified from genomic DNA of H. pylori strain 60190 and cloned into plasmids encoding the transcription activation domain (pAD) 1 and/or the DNA binding domain (pBD) of the GAL4 Two-hybrid Phagemid system (Stratagene). The sequences of the primers used for cloning the different vacA fragments into the yeast twohybrid vectors are described in Table I . Primers combinations, restriction site used for cloning the PCR products into the pAD and pBD vectors, and the amino acid numbers of the VacA fragments are described in Table II .
To facilitate the introduction of in-frame deletion mutations into the pAD33 plasmid, vacA sequences encoding p-33 mutant domains were PCR-amplified from genomic DNA of previously described H. pylori strains harboring the specific in-frame vacA deletions (39) and cloned into the pAD vector (Table II) . vacA sequences encoding p-55 fragments were PCR-amplified from genomic DNA of H. pylori strain 60190 (Table  II) and were cloned into the pBD vector. The entire vacA fragment in each p-33 and p-55 encoding plasmid was analyzed by nucleotide sequence analysis in order to verify that no unintended mutations had been introduced.
Yeast Methods-Yeast strains were co-transformed with 400 ng of individual plasmids using the lithium acetate method (44) and cultured on SD medium supplemented with the required amino acids and glucose at 30°C as described in the GAL4 Two-hybrid Phagemid manual (Stratagene). For a positive protein-protein interaction control, we cotransformed the yeast with pBD-WT and pAD-WT plasmids, which encode fusion proteins consisting of amino acids 132-236 of wild-type cI, fragment C, together with either the GAL4-BD or -AD, respectively. For a negative control (i.e. two proteins that do not interact), we used the pAD-WT plasmid co-transformed with a pBD-pLamin C plasmid, which expresses the BD of GAL4 fused to amino acids 60 -230 of human lamin C. We also used plasmids pAD-Mut and pBD-Mut, which encode a mutated (E233K) cI, fragment C, fused to either the GAL4-AD or -BD. The cI-E233K mutation interferes with the interaction between the cI monomers, resulting in a protein-protein interaction that is weaker than that of wild-type proteins. Plasmids expressing positive and negative interaction control proteins were obtained from Stratagene.
One colony of each co-transformant was grown in 2 ml of SD medium containing 2% (w/v) glucose and lacking Trp and Leu (SDϪLeu,ϪTrp) at 30°C with aeration for ϳ24 h. Cultures were then normalized to an A 600 of about 0.26 in a final volume of 100 l of SDϪLeu,ϪTrp,ϪHis broth, and 10-fold serially diluted into SDϪLeu,ϪTrp,ϪHis broth in a microtiter plate. Diluted cultures (5 l) were seeded on duplicate SDϪLeu,ϪTrp plates (selection for plasmids) and SDϪLeu,ϪTrp,ϪHis plates (selection for protein-protein interactions) and incubated at 30°C for 3-10 days.
To confirm the occurrence of protein-protein interactions, a ␤-galactosidase liquid assay was performed using the Yeast ␤-Galactosidase Assay Kit as described by the manufacturer (Pierce). Briefly, individual co-transformants were grown in 2 ml of SDϪLeu,ϪTrp medium containing 2% (w/v) glucose at 30°C with aeration for ϳ16 -24 h until cultures reached mid-log phase (A 600 0.4 -0.5). 150-l aliquots of the cultures were then mixed with 150 l of the working solution (equal volume of 2ϫ ␤-Galactosidase Assay Buffer and Y-PER TM Reagent) and then incubated at 37°C until solutions turned yellow (ϳ1-4 h), at which time reactions were stopped by the addition of 175 l of ␤-Galactosidase Assay Stop Solution. The time required for yellow color development was recorded for each tube. The A 410 values of clarified reaction supernatants (200 l) were measured in a 96-well plate, and the ␤-galactosidase activity was calculated by using the Miller equation as described in the Yeast ␤-Galactosidase Assay Protocol (Pierce). The values presented are the average of at least three independent cotransformants (means Ϯ S.D.). Statistical significance was analyzed using Student's t test.
Introduction of DNA Encoding a FLAG Tag Epitope and Enterokinase Site into the vacA Gene of H. pylori 60190 -To modify the vacA gene so that it encoded a VacA protein containing a FLAG tag (DYK-DADDDK) and an enterokinase cleavage site (after the underlined K), complementary primers OP2891 and OP2892 encoding the FLAG epitope (Table I) were annealed and ligated into the unique StuI site of plasmid pA178 (45) . The resulting plasmid, pA178-FLAG, contained a sequence encoding the FLAG epitope in the proper orientation inserted between amino acids 317 and 318 of VacA. Plasmid pA178-FLAG was then used to transform H. pylori strain VM022 (39) , and transformants were selected by growth on 5.5% sucrose plates, as described previously (39, 46) . Analysis of a single transformant (H. pylori VM088) by PCR and by DNA sequence analysis confirmed that the sequence encoding the FLAG epitope and the enterokinase cleavage site had been introduced into the desired location. 
Purification of Oligomeric Forms of VacA-VacA was purified from broth culture supernatants of H. pylori as described previously (29) . Briefly, broth culture supernatant proteins were concentrated by precipitation with a 50% saturated solution of ammonium sulfate and resuspended in phosphate-buffered saline. Oligomeric VacA (ϳ1,000 kDa) was purified by gel filtration chromatography using a Superose 6HR 16/50 column. To analyze the oligomeric state of the enterokinasetreated FLAG-VacA, 40 g of cleaved toxin was applied to a Superose 6HR 16/50 column, and fractions (2 ml each) were collected. Fractions were analyzed by immunoblot analysis with an anti-VacA serum.
Proteolysis of FLAG-VacA with Enterokinase-Purified FLAG-VacA was proteolytically cleaved with enterokinase as described by the Recombinant Enterokinase Kit manual (Novagen). Briefly, 10 g of purified FLAG-VacA was incubated with 1 unit of enterokinase and 5 l of 10ϫ enterokinase cleavage buffer in a final volume of 50 l for Ն16 h at room temperature. For mock treatment, FLAG-VacA was treated in the same manner but without enterokinase. Proteolysis of the full-length FLAG-VacA was assessed by immunoblot analysis using an anti-VacA serum or the M2 monoclonal anti-FLAG antibody (Sigma).
Cell Culture and Vacuolating Assays-HeLa cells were grown in minimal essential medium (modified Eagle's medium containing Earle's salts) supplemented with 10% fetal bovine serum. For vacuolating assays, HeLa cells were seeded (1.5 ϫ 10 4 ) into 96-well plates 24 h prior to each experiment. Protein concentrations of the purified VacA toxins were determined by using a Micro-BCA assay (Pierce). Serial dilutions of purified VacA toxins (standardized by protein concentration) were incubated with cells in serum-free medium containing 10 mM ammonium chloride as described previously (5) . Purified VacA preparations (VacA, FLAG-VacA, and cleaved FLAG-VacA) were acid-activated by adjusting them to pH 3 by the addition of 250 mM hydrochloric acid before they were added to cell culture wells (47, 48) . After 24 h of incubation of VacA toxins with the cell monolayers, cells were examined by inverted light microscopy. Toxins that induced vacuoles in more than 50% of the cells were scored positive for vacuolating cytotoxic activity. Vacuolating activity was also quantified by a neutral red uptake assay as described previously (49) . Neutral red uptake data are presented as A 540 values (means Ϯ S.D.). Statistical significance was analyzed by using Student's t test.
RESULTS

Detection of p-33/p-55 Interactions in a Yeast Two-hybrid
System-Previous studies have reported that 88-kDa VacA monomers commonly undergo spontaneous degradation, yielding 33-and 55-kDa fragments ( Fig. 1) (11, 27, 28) . These two fragments have been considered to represent two domains or subunits of VacA (11, 20, 30, 31) . To investigate potential interactions among these two VacA fragments, we investigated whether they were able to interact in a GAL4 transcription activator yeast two-hybrid system (GAL4 Two-hybrid Phagemid; Stratagene) (50) . This particular yeast two-hybrid system was selected based on the low expression of the bait and prey fusion proteins which, in turn, is thought to reduce the number of false positive interactions (51) . In this system, the yeast GAL4 transcription activator has been divided into the following two separate functional domains (52): (i) the transcription activation domain (AD) present on plasmid pAD-GAL4 -2.1 (pAD), which encodes for the LEU2 gene as a selectable marker; and (ii) the DNA binding domain (BD) present on the plasmid pBD-GAL4-Cam (pBD), which encodes for the TRP1 gene as a selectable marker. If two fusion proteins interact in this system, they will bring in close proximity the GAL4 transcription activation domain and the GAL4 DNA binding domain to the GAL4/GAL1 promoters, which in turn will initiate the transcription of the HIS3 and lacZ reporter genes. Proteinprotein interactions are then detected by the ability of cotransformed yeast cells to grow in selective medium lacking Leu, Trp, and His (SDϪLeu,ϪTrp,ϪHis) and by production of ␤-galactosidase activity.
vacA sequences encoding p-33 and p-55 fragments were cloned into plasmids encoding the transcription activation domain (pAD) and the DNA binding domain (pBD), generating plasmids pAD33, pBD33, pAD55, and pBD55 (Table II) . In order to test whether interactions among VacA fragments could be detected in this system, we co-transformed all four possible combinations of the p-33 and p-55 yeast two-hybrid plasmids into the yeast reporter strain (Fig. 2A) . Serial dilutions of co-transformed yeast were then tested for their ability to grow on SD medium lacking Leu and Trp, as well as SD medium lacking Leu, Trp, and His. All of the co-transformed yeast grew on the former media, which confirmed that the transformation had been successful and provided an indication of the relative number of co-transformed yeast cells present in each dilution. Yeast co-transformed with plasmids encoding p-33 and p-55 fusion proteins grew in SD medium lacking Leu, Trp, and His, indicating that there was an interaction between these fusion proteins (Fig. 2B) . In contrast, yeast co-transformed with plasmids encoding p-33/p-33 or p-55/p-55 fusion proteins did not grow on SD medium lacking Leu, Trp, and His (Fig. 2B) . The p-33/p-55 interaction observed within co-transformed yeast was further confirmed by the analysis of ␤-galactosidase activity, which reflects the activation of the lacZ reporter gene (Fig.  2C) . The p-33/p-55 interaction was independent of the protein fused (AD or BD) to the p-33 or p-55 fragment, because both combinations of tested plasmids (pAD33/pBD55 and pAD55/ pBD33) were able to activate the HIS3 and lacZ reporters (Fig.  2, B and C) . Furthermore, none of the fusion constructs were able to activate the reporter genes when transformed alone into the yeast reporter strain (data not shown), indicating that the interaction detected in the yeast two-hybrid system is due to a specific interaction between p-33 and p-55 VacA fragments.
p-33/p-55 Interactions of VacA Mutant Fragments-Previously, we have reported the construction of H. pylori strains containing in-frame deletion mutations in the vacA gene (39) . Results from this previous study indicated that a mutant VacA protein with a deletion of amino acids 6 -27, VacA-(⌬6 -27), could assemble into water-soluble oligomeric structures and suggested that VacA proteins containing ⌬28 -108, ⌬56 -83, ⌬85-127, or ⌬112-196 deletion mutations were defective in the capacity for oligomer assembly (39) (Table III) . We hypothesized that the latter mutations might disrupt interactions between p-33 and p-55 domains, and that such a defect might account for failure of these VacA mutant proteins to form oligomeric structures. In order to test directly this hypothesis, we introduced these same deletion mutations (i.e. ⌬6 -27, ⌬28 -108, ⌬56 -83, ⌬85-127, and ⌬112-196) into the pAD33 plasmid, as described under "Experimental Procedures" (Table II) . The pAD33 plasmid was chosen for mutagenesis based on the observation that higher reporter activity was detected when wild-type p-33 was fused to the transcription activation domain and wild-type p-55 fused to the DNA binding domain, compared with the opposite orientation (Fig. 2C) . Mutant pAD33 plasmids were co-transformed into yeast along with the wildtype pBD55 plasmid, and the activation of the reporter genes C and D) from H. pylori 60190 were electrophoresed on a 10% SDS-polyacrylamide gel, transferred to a nitrocellulose membrane, and immunoblotted with polyclonal antiVacA serum. These preparations exhibit varying degrees of spontaneous VacA proteolysis into p-33 and p-55 fragments.
was analyzed as described above. Wild-type pAD33 and pAD⌬6 -27p-33 were each able to activate both the HIS3 and lacZ reporter genes when co-transformed with wild-type pBD55 (Fig. 3) , whereas the other pAD33 mutants failed to activate the reporter genes when co-transformed with wildtype pBD55. The p-55/⌬6 -27p-33 interaction was specific, because yeast cells co-transformed with pBD33 and pAD⌬6 -27p-33 were not able to activate the reporter genes (data not shown). Thus, mutations that disrupted oligomerization of VacA secreted by H. pylori (39) also disrupted p-33/p-55 interactions in the yeast two-hybrid system (Table III) . Interestingly, yeast co-transformed with plasmids expressing ⌬6 -27p-33 and p-55 consistently produced higher levels of ␤-galactosidase activity than did yeast expressing wild-type p-33 and p-55 (Fig. 3B) .
To further map putative amino acid sequences involved in the p-33/p-55 interaction, we generated different p-55 fragments (i.e. encoding amino acids 313-700, 313-550, 313-478, 550 -821, and 479 -821) and cloned them into the pBD vector as described under "Experimental Procedures" (Table II) .
These new fusion proteins were tested for their ability to interact with wild-type p-33 as described above (Fig. 4A) . Yeast co-transformed with the pAD33 plasmid and plasmids expressing p-55 fragments containing amino acids 313-700, 313-550, or 313-478 were able to grow on SDϪLeu,ϪTrp,ϪHis, whereas yeast co-transformed with the pAD33 plasmid and plasmids expressing p-55 fragments containing amino acids 479 -821 or 550 -821 were not able to grow (Fig. 4B) . The former group of co-transformed yeast grew slowly on SDϪLeu,ϪTrp,ϪHis plates and expressed a relatively low level of ␤-galactosidase activity (Fig. 4, B and C) . This suggests that the interactions c Interaction between p-33 and p-55 VacA fragments was determined using the yeast two-hybrid system (Y2H) as described in the text.
d Oligomer formation of full-length VacA toxins secreted by H. pylori was analyzed by determining whether these proteins eluted as large oligomeric structures (Ϸ1,000 kDa) from a Superose 6 HR 16/50 FPLC column (5, 39) .
e Cytotoxic vacuolating activity of VacA toxins for HeLa cells was analyzed as described under "Experimental Procedures." between the 313-700, 313-550, and 313-478 p-55 fragments and p-33 are weaker than the interaction between full-length wild-type p-55 and p-33. When we co-transformed yeast with a mutated version of the positive control plasmids (mutant ϩ control described under "Experimental Procedures") known to encode proteins that interact with relatively low affinity (53), a similar low level of ␤-galactosidase activity was detected (Fig.  4C) . The data obtained with these mutant control plasmids support our conclusion that the p-33 interacts weakly with 313-700, 313-550, and 313-478 p-55 fragments. (11, 27, 28) . However, it remains unclear whether proteolytic cleavage of the 88-kDa VacA protein into 33-and 55-kDa fragments alters VacA cytotoxic activity or alters its oligomeric structure. One reason why this issue has not yet been addressed in any detail is that it has been difficult to experimentally induce the desired cleavage. VacA preparations commonly undergo partial proteolytic degradation during storage (Fig. 1) , but complete proteolysis of the 88-kDa VacA protein into smaller fragments occurs uncommonly. Furthermore, spontaneous proteolytic degradation of VacA often involves cleavage at multiple sites (27) .
In order to test experimentally whether cleavage of VacA into 33-and 55-kDa fragments alters its activity, we sought to develop a system in which a protease could be used to induce proteolytic cleavage at a specific site located between the 33-and 55-kDa domains. To accomplish this, we constructed a modified H. pylori strain in which an oligonucleotide encoding the FLAG tag epitope and an enterokinase cleavage site was inserted into the vacA allele of H. pylori 60190 as described under "Experimental Procedures" (Fig. 5A) . This enterokinase cleavage site (Fig. 5B) provided a mechanism by which the 88-kDa VacA protein could be specifically cleaved into fragments similar to the spontaneously arising 33-and 55-kDa VacA fragments. Immunoblotting studies with an anti-VacA serum indicated that an H. pylori strain (VM088) containing this engineered vacA allele expressed and secreted VacA at levels similar to wild-type H. pylori strain 60190 (data not shown). The FLAG-VacA toxin was purified from H. pylori VM088 culture supernatant as large oligomeric structures that eluted from a gel filtration column in the same fractions as wild-type VacA. Purified FLAG-VacA underwent spontaneous partial degradation into two forms of the p-33 and p-55 VacA fragments (Fig. 6B, 1st lane) , which is consistent with previous observations suggesting that proteolysis can occur at multiple sites (27) . As expected, enterokinase treatment resulted in the complete cleavage of the full-length FLAG-VacA into p-55 and FLAG-tagged p-33 (FLAGp-33) fragments as seen by immunoblot analysis using an anti-VacA serum or an anti-FLAG monoclonal antibody (Fig. 6) . In contrast, enterokinase treatment of the wild-type 60190 VacA toxin (lacking the FLAG tag epitope) did not induce any detectable cleavage (data not shown).
Vacuolating Toxic Activity of Intact FLAG-VacA and Proteolytically Cleaved FLAG-VacA-We next compared the cytotoxic activities of intact FLAG-VacA and FLAG-VacA that had been proteolytically cleaved into p-55 and FLAGp-33 fragments. Purified oligomeric FLAG-VacA was either treated with enterokinase or mock-treated as described under "Experimental Procedures." Proteins were then acid-activated (a procedure used to enhance vacuolating activity) and added to the neutral-pH medium overlying HeLa cells (47, 48) . The vacuolating activities of intact FLAG-VacA and proteolytically cleaved FLAGVacA were indistinguishable as determined by microscopic examination (data not shown) and analysis by a neutral red uptake assay (Fig. 7) . The vacuolating activities of full-length FLAG-VacA and proteolytically cleaved FLAG-VacA were not detectably different when tested in a range of toxin concentrations from 2.5 to 10 g/ml (Fig. 7 and data not shown) .
VacA purified from wild-type H. pylori strain 60190 exhibits very little vacuolating toxic activity unless it is acid-or alkaline-activated prior to contact with cells (47, 48, 54) . We hypothesized that proteolytically cleaved VacA might exhibit vacuolating toxic activity even in the absence of acid activation. However, neither intact nor proteolytically cleaved FLAGVacA exhibited detectable vacuolating activity in the absence of acid activation, as determined by microscopic examination (data not shown) and analysis by a neutral red uptake assay (Fig. 7) .
Oligomeric State of Proteolytically Cleaved FLAG-VacA-
The secreted FLAG-VacA assembles into large water-soluble oligomeric structures (Fig. 8A) , in a manner similar to wildtype VacA (5, 29) . To determine whether p-33 and p-55 fragments of VacA remained physically associated following proteolytic cleavage of FLAG-VacA, enterokinase-treated FLAGVacA was fractionated by gel filtration chromatography, and its elution pattern was monitored by immunoblot analysis with an anti-VacA serum. Proteolytically cleaved FLAG-VacA and intact FLAG-VacA were found to elute in the same high molecular mass fractions (Fig. 8) but not in any of the lower molecular mass fractions (data not shown), indicating that VacA fragments (i.e. FLAGp-33 and p-55) remain associated within an oligomeric structure (Fig. 8) .
DISCUSSION
Over the past decade, multiple lines of investigation have provided evidence for the occurrence of homotypic interactions among VacA proteins (5, 11, 31, 34, 35, 39, 45) . The earliest evidence suggesting oligomerization of VacA proteins was the observation that purified VacA from H. pylori broth culture supernatant assembles into structures of ϳ1,000 kDa in mass, corresponding to a buoyant density of about 22 S (5, 29) . Ultrastructural studies have shown that these VacA complexes FIG. 6 . Enterokinase treatment of full-length FLAG-VacA results in production of 33-and 55-kDa VacA fragments. Purified VacA from H. pylori VM088 (10 g) was either treated with enterokinase (1 unit) or mock-treated as described under "Experimental Procedures." Toxins (100 ng) were then electrophoresed on a 10% SDSpolyacrylamide gel, transferred to a nitrocellulose membrane, and reacted with anti-FLAG M2 monoclonal antibody (Sigma) (A). The blot was then stripped and reacted with polyclonal anti-VacA serum (B). Enterokinase treatment induced complete cleavage of full-length FLAG-VacA into ϳ33-and ϳ55-kDa fragments. In preparations of FLAG-VacA not treated with enterokinase, the FLAG tag epitope is detected predominantly in full-length 88-kDa VacA and in the p-55 fragment (A, 1st lane) . Only the ϳ33-kDa fragment retained the FLAG tag epitope after enterokinase treatment (A, 2nd lane).
FIG. 7.
Vacuolating cytotoxic activity of intact and proteolytically cleaved FLAG-VacA. Identical aliquots of purified FLAG-VacA were either treated with enterokinase as described under "Experimental Procedures" or left untreated. Toxins were then either acid-activated (pH 3) or left untreated and added to tissue culture medium overlying HeLa cells. The final VacA concentration of all samples was 5 g/ml.
Vacuolating activity was quantified using a neutral red uptake assay. Enterokinase-treated FLAG-VacA and untreated FLAG-VacA did not differ significantly in vacuolating cytotoxin activity. Furthermore, both enterokinase-treated and untreated FLAG-VacA required acid activation in order to induce vacuolating activity. Results represent the mean Ϯ S.D. from triplicate samples and are expressed as a percent of neutral red uptake induced by full-length acid-activated FLAG-VacA.
FIG. 5.
Construction of H. pylori VM088 using a sacB-based counter-selection approach. A, the pMM389 plasmid contains a vacA fragment from H. pylori strain 60190 and a sacB/kan cassette (39, 46) . Transformation of H. pylori 60190 with pMM389 yielded a kanamycin-resistant transformant designated H. pylori VM022 (39) . H. pylori VM022 was transformed with pA178-FLAG plasmid; transformants were selected on sucrose-containing medium, and a strain (H. pylori VM088) with a sequence encoding a FLAG tag with an enterokinase site inserted into the vacA gene was thereby obtained. B, VacA spontaneously degrades into two fragments, termed p-33 and p-55. Open arrows indicate the most common site where wild-type VacA from H. pylori 60190 undergoes spontaneous cleavage and the resulting p-33 and p-55 fragments (27) . Closed arrows indicate the enterokinase cleavage site introduced with the FLAG tag epitope and the FLAGp-33 and p-55 fragments generated after enterokinase cleavage. The amino acid numbering system used in this figure is based on designating the first amino acid (alanine) of the mature secreted VacA toxin of strain 60190 as amino acid 1. have a flower-like shape and that they contain anywhere from 6 to 14 subunits (29, 30, 42) . These flower-shaped structures disassemble into VacA monomers after exposure to acid or alkaline pH and then reassemble into oligomeric structures after neutralization (29, 54) . Further evidence for the assembly of VacA into oligomeric structures has resulted from experiments in which two different VacA toxins have been shown to form mixed oligomeric structures (34, 39, 45) . VacA-VacA interactions have also been detected by transiently transfecting cells with different fluorescently tagged VacA-expressing plasmids and using fluorescent resonance energy transfer methodology (35) .
Although many lines of evidence indicate that VacA can form oligomeric structures, thus far there has been relatively little investigation of the specific VacA-VacA interactions that are required for assembly into higher order structures. In this study we investigated the role of p-33 and p-55 interactions in oligomer formation by VacA. These two VacA fragments have been considered to represent two domains or subunits of VacA. In the present work, we demonstrated that p-33/p-55 interactions can be detected using the yeast two-hybrid system. In contrast, p-33/p-33 and p-55/p-55 interactions were not detected in this system. The lack of detectable p-33/p-33 and p-55/p-55 interactions was not due to the lack of expression of these fusion proteins in the yeast, because all four fusion proteins were able to interact when tested for p-33/p-55 interactions. Importantly, the failure to detect p-33/p-33 or p-55/p-55 interactions in the yeast two-hybrid system does not exclude the possibility that such interactions might occur in other environments. A previous study analyzed the properties of a modified p-55 fragment secreted by H. pylori, and reported that this protein could form homodimers but not large oligomeric structures (31) . However, the VacA protein analyzed in that study contained at least 27 residues of the p-33 domain in addition to the p-55 fragment (31). Another previous study provided evidence that an N-terminal hydrophobic portion of the p-33 fragment could undergo transmembrane protein homodimerization within E. coli membranes (40, 55) . The inability to detect p-33/p-33 interactions with the yeast two-hybrid system is consistent with a model in which p-33/p-33 interactions occur only within membranes (40, 55) .
In an effort to map putative interacting regions within p-33 and p-55, we used the yeast two-hybrid system to analyze a series of mutant proteins containing internal deletions, as well as truncated VacA proteins. The yeast two-hybrid data suggest that amino acids 28 -196 within the p-33 domain and 313-478 within the p-55 domain contribute to the p-33/p-55 interaction. Only one of the p-33 deletion mutants (⌬6 -27p-33) was able to interact with wild-type p-55. VacA amino acids 6 -27 comprise a hydrophobic region of VacA that inserts into lipid membranes and is required for VacA cytotoxic and membrane anion-channel activity (39, 40, 55) . Interestingly, when co-expressed with p-55, the ⌬6 -27p-33 mutant fragment induced higher reporter activity in the yeast two-hybrid assay than did wild-type p-33. A possible explanation for this result could be that the ⌬6 -27p-33 mutant fragment is able to translocate to the yeast nuclei more efficiently than can the wild-type p-33, since previously it has been reported (56) that hydrophobic sequences decrease nuclear protein translocation. Another possibility could be that the ⌬6 -27p-33 mutant fragment interacts more strongly with the wild-p-55 fragment than does wild-type p-33.
By constructing a FLAG-VacA toxin, which can be efficiently cleaved into p-33 and p-55 domains, we were able to study the p-33/p-55 interactions that occur within the VacA oligomer produced by H. pylori. Our results (Fig. 8) clearly indicate that p-33 and p-55 fragments remain physically associated after proteolytic cleavage of VacA. In agreement with this interpretation, when we incubated proteolytically cleaved FLAG-VacA with an Anti-FLAG M2 Affinity Gel (Sigma), both the p-55 and FLAGp-33 fragments were captured (data not shown). Neither FLAGp-33 nor p-55 fragments could be eluted from the affinity gel under pH conditions ranging from 7.5 to 4.5, nor with 1% CHAPS, 10% Triton X-100, or 2 M urea, suggesting that there is a stable physical interaction between the p-33 and p-55 VacA domains (data not shown). Furthermore, our results demonstrate that the vacuolating activity of intact FLAG-VacA and fully proteolytically cleaved FLAG-VacA is indistinguishable (Fig. 7) . A likely explanation for intact activity of proteolytically cleaved VacA is that the fragments remain associated and do not undergo any extensive adverse conformational changes (unfolding) following proteolytic cleavage.
Two lines of evidence presented in the current study suggest that the p-33/p-55 interactions play an important role in VacA oligomer assembly. First, the intact oligomeric structure of proteolytically cleaved VacA indicates that p-33/p-55 interactions occur within VacA oligomers. Second, the properties of mutant p-33 fragments in the yeast two-hybrid system correlate perfectly with the capacity of secreted H. pylori mutant proteins to form oligomeric structures. This suggests that mutations disrupting the p-33/p-55 interaction also disrupt the formation of large VacA oligomeric structures. It is possible that there may be two different types of interactions: (i) intramolecular interactions between the p-33 and p-55 domains of an individual VacA monomer that might be important for proper folding of the VacA monomers within the oligomeric structures, and (ii) intermolecular interaction between p-33 and p-55 domains of different 88-kDa molecules to form the larger oligomeric structures. Currently, we are not able to differentiate between these two interactions.
VacA toxins that fail to oligomerize consistently lack vacuolating cytotoxic activity, suggesting that oligomerization is im- portant for VacA activity (39) . This hypothesis is supported by the observation that neither p-33 nor p-55 is able to exhibit vacuolating cytotoxic activity in a transient transfection assay when expressed individually within cells (32, 34, 41) . In contrast, when both domains are co-expressed within cells, they interact and exhibit vacuolating cytotoxic activity (32, 34) . Thus, the data presented in the current study, as well as data obtained using other systems, indicate that p-33/p-55 interactions are essential for VacA assembly into oligomeric structures and also for vacuolating cytotoxic activity.
Oligomerization is an important feature of many proteins, in particular pore-forming proteins (57, 58) . Examples of these proteins include perforin, Bcl-2 family members, as well as several bacterial toxins. Several bacterial pore-forming toxins, including protective antigen of Bacillus anthracis, ␣-hemolysin of Staphylococcus aureus, streptolysin O of Streptococcus pyogenes, ␣-toxin of Clostridium septicum, El Tor cytolysin of Vibrio cholera, and aerolysin of Aeromonas hydrophila, assemble in target cell membranes forming transmembrane channels (59 -65) . These proteins are interesting because, like VacA, they are synthesized as water-soluble molecules but then insert into membranes. Further studies of the processes by which these toxins assemble into oligomeric structures may ultimately lead to the development of therapeutic inhibitors that block the oligomerization and the activity of these toxins in vivo.
